Fig. 1.

Prevalence of Untreated Hypertension and those Participants Qualifying for Anti-Hypertensive Pharmacothearpy.*

*Excludes those with diabetes mellitus or chronic kidney disease as treatment recommendations are similar.

□ p<0.001 for South Asians, p<0.001 for Blacks, p = 0.573 for Hispanics, and p = 0.118 for Chinese-Americans (White as reference) for comparison of percentages across each race/ethnicity group

□□ p<0.001 South Asians, p<0.001 for Blacks, p = 0.606 for Hispanics, and p = 0.430 for Chinese-Americans for (White as reference) for comparison of percentages across each race/ethnicity group.

ACC/AHA – American College of Cardiology/American Heart Association; ASCVD Risk – atherosclerotic cardiovascular disease risk calculated by the Pooled Cohorts Equations; HTN – hypertension; JNC7 - Seventh Report of the Joint National Committee on Treatment of High Blood-Pressure.

Blood Pressure Definitions: 2017 ACC/AHA: Normal: systolic blood pressure (SBP) <120 mmHg and diastolic blood pressure (DBP) <80 mmHg; Elevated Blood Pressure: SBP 120–129 mmHg and DBP <80 mmHg; Stage 1: SBP 130–139 or DBP 80–89 mmHg; Stage 2: SBP ≥140 mmHg or DBP ≥ 90mmHg

JNC7: Normal: SBP <120 and DBP <80; PreHTN: SBP 120–139 mmHg or DBP 80–89 mmHg; Stage 1: SBP 140–159 or DBP 90–99 mmHg; Stage 2: SBP ≥160 mmHg or DBP ≥100 mmHg.